Funding This study was supported by grants from the Center of Innovation Program from the Japan Science and Technology Agency, Grant Number JPMJCE1301, and from the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP) Technologies for creating next-generation agriculture, forestry and fisheries. Ethics declarations Conflict of interest The authors declare that they have no conflict of interest
Semaglutide is part of the new generation of GLP-1 RA medications, which have greater weight loss efficacy than liraglutide ( 7 )
*On a forward strand, which SelfDecode uses by default, the alleles for the above SNP, rs1801133, are G (corresponds to C) and A (corresponds to T)
Diabetes group recommends against compounded GLP-1s
Late-stage clinical trials have examined the cognitive effects of GLP-1 receptor agonists, according to Edelmayer